Detalles de la búsqueda
1.
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
Rheumatology (Oxford)
; 60(1): 140-146, 2021 01 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32591790
2.
Drug retention of biological DMARD in rheumatoid arthritis patients: the role of baseline characteristics and disease evolution.
Rheumatology (Oxford)
; 58(12): 2221-2229, 2019 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31209481
3.
Viral respiratory infections in patients treated with hydroxychloroquine.
Clin Exp Rheumatol
; 39(5): 1146, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33886463
4.
Developing and externally validating multinomial prediction models for methotrexate treatment outcomes in patients with rheumatoid arthritis: results from an international collaboration.
J Clin Epidemiol
; 166: 111239, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38072179
5.
Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: Results from the international TOCERRA and PANABA observational collaborative studies.
Joint Bone Spine
; 91(2): 105671, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38042363
6.
How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway.
Eur J Intern Med
; 115: 55-61, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37355347
7.
Discontinuation rate of sulfasalazine, leflunomide and methotrexate due to adverse events in a real-life setting (NOR-DMARD).
Rheumatol Adv Pract
; 7(2): rkad053, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37431434
8.
Treatment Response to Tumor Necrosis Factor Inhibitors and Methotrexate Monotherapy in Adults With Juvenile Idiopathic Arthritis: Data From NOR-DMARD.
J Rheumatol
; 50(4): 538-547, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36379571
9.
Follow-Up of Patients With Axial Spondyloarthritis in Specialist Health Care With Remote Monitoring and Self-Monitoring Compared With Regular Face-to-Face Follow-Up Visits (the ReMonit Study): Protocol for a Randomized, Controlled Open-Label Noninferiority Trial.
JMIR Res Protoc
; 12: e52872, 2023 Dec 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38150310
10.
Commonalities and differences in set-up and data collection across European spondyloarthritis registries - results from the EuroSpA collaboration.
Arthritis Res Ther
; 25(1): 205, 2023 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37858143
11.
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries.
Arthritis Care Res (Hoboken)
; 74(7): 1205-1218, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33460531
12.
Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration.
Semin Arthritis Rheum
; 56: 152081, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35985172
13.
Effectiveness of a Second Biologic After Failure of a Non-tumor Necrosis Factor Inhibitor As First Biologic in Rheumatoid Arthritis.
J Rheumatol
; 48(10): 1512-1518, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33649069
14.
Does Older Age have an Impact on Rituximab Efficacy and Safety? Results from the NOR-DMARD Register.
Drugs Aging
; 37(8): 617-626, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32648248
15.
Comparative effectiveness of TNF inhibitors and tocilizumab with and without conventional synthetic disease-modifying antirheumatic drugs in a pan-European observational cohort of bio-naïve patients with rheumatoid arthritis.
Semin Arthritis Rheum
; 50(1): 17-24, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31280937
16.
Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study.
RMD Open
; 4(2): e000773, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30488000
17.
Corrigendum to 'Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration' [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081].
Semin Arthritis Rheum
; 58: 152141, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36463635
Resultados
1 -
17
de 17
1
Próxima >
>>